643069-46-9

Basic information

• Product Name: 4-Bromo-5-methoxyquinoline
• Synonyms: 4-Bromo-5-methoxyquinoline;7-(trifluoromethyl)-2-methylquinoline
• CAS NO: 643069-46-9
• Molecular Formula: C₁₀H₈BrNO
• Molecular Weight: 238.08062
• Mol File: 643069-46-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 4-Bromo-5-methoxyquinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Bromo-5-methoxyquinoline(643069-46-9)
• EPA Substance Registry System: 4-Bromo-5-methoxyquinoline(643069-46-9)

Safety Data

• Hazardous Substances Data: 643069-46-9(Hazardous Substances Data)

Usage

General Description

4-Bromo-5-methoxyquinoline is a chemical compound with the molecular formula C10H8BrNO. It is a quinoline derivative with a bromine atom at the 4th position and a methoxy group at the 5th position of the quinoline ring. 4-Bromo-5-methoxyquinoline has potential applications in pharmaceutical and organic synthesis. It can be used as a building block for the synthesis of various biologically active molecules and pharmaceutical drugs. Additionally, it has been studied for its potential antimicrobial and antiviral properties, making it a valuable compound in the field of medicinal chemistry. However, further research is needed to fully understand its biological and pharmacological properties.

Upstream product

• 90924-16-6 5--methoxyquinoline N--oxide 
• 643069-43-6 5-methoxy-1H-quinolin-4-one 

Downstream Products

• 1229624-35-4 C₂₂H₂₉N₃O₅ 

Relevant articles and documents

A highly practical and convenient halogenation of fused heterocyclic N-oxides

A novel, simple and practical method for the regioselective halogenation of fused heterocyclic N-oxides has been developed. It employs Vilsmeier reagent, generated in situ by POX3and DMF, as both the activating agent and the nucleophilic halide source. The method is amenable across a broad range of substrates, including quinolines, isoquinolines and the diazine N-oxides, possessing a variety of substitution patterns. Furthermore, all of the reagents associated are cheap and easy to obtain. The potential extension of this method to a one-pot oxidation/halogenation sequence that obviates the need for isolation of the N-oxide intermediates is also presented.

ANTIBACTERIAL COMPOUNDS

Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly man